Saturday , November 25 2017
Home / Therapies / Devices / Dexcom G4 Platinum with SHARE Gets FDA Approval

Dexcom G4 Platinum with SHARE Gets FDA Approval

 

The FDA has approved Dexcom’s G4 PLATINUM Continuous Glucose Monitoring System with Share. The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient’s receiver and an app on the patient’s smartphone to transmit glucose information to apps on the mobile devices of up to five designated recipients, or "followers," without the need for a dedicated docking cradle. These followers can remotely monitor a patient’s glucose information and receive alert notifications from almost anywhere, initially via their Apple iPhone or iPod touch and in the future on Android devices, giving them peace of mind and reassurance when they are apart. The "Share" and "Follower" apps will be available early March 2015 on the Apple App Store at no charge.